Clinical Cognitive Affective Neuroscience Lab
Discover MoreT01 CX002088-03
This study uses EEG to identify biomarkers of response and mechanisms of change as they relate to transcranial magnetic stimulation targeting dorsolateral prefrontal cortex in Veterans with treatment-resistant depression.
Dr. Klumpp's Role: Site Co-Investigator at Edward Hines, Jr. VA Hospital, IL
R33 MH116089-03 NIH/NIMH
The study proposes to modify attentional bias by reinforcing attention to non-threat faces with reward (music) while training attention away from threat faces. The R33 randomized trial will test whether change in attention is associated with clinical improvement.
R21 MH121852-01
This study combines actigraphy with the smartphone app ‘BiAffect’ to understand digital behaviors, sleep, and circadian patterns on cognitive function and emotion processing in individuals with major depressive disorder or insomnia.
R61 MH117157-02 NIH/NIMH
Morning bright light treatment is a promising intervention for posttraumatic stress disorder. The study evaluates links between morning light treatment over the course of 4 weeks and mechanisms of symptom improvement.
R01 MH112705-01 NIH/NIMH
The study examined mechanisms of change that underlie CBT, and identify predictors of CBT response, in patients with major depressive disorder or social anxiety disorder.
R61 MH116089-01 NIH/NIMH
The study modifies attentional bias by reinforcing attention to non-threat faces with reward (music) while training attention away from threat faces. The long-term objective is to test whether such attentional bias modification improves social anxiety symptoms and quality of life.
University of Illinois Chicago Center for Clinical and Translational Science Pilot Grant
The study examined links between chemotherapy and/or hormone therapy with neurocognitive performance and brain response (i.e., EEG/event-related potentials) in females with breast cancer to understand the impact of treatment on cognitive deficiencies.
R61 MH111935-01 NIH/NIMH
Trauma-focused psychotherapy is first-line psychotherapy for posttraumatic stress disorder (PTSD) and is believed to work through fear extinction mechanisms. While generally effective, many remain symptomatic after treatment. Animal studies have shown that activation of the cannabinoid system during extinction learning enhances fear extinction and its retention. Specifically, CB1 receptor agonists, such as Δ9-tetrahydrocannibinol (THC), can facilitate extinction recall by preventing recovery of extinguished fear in rats. This aim of this study is to use Δ9-tetrahydrocannibinol to increase retention of fear extinction in PTSD to improve clinical outcome.
R01 MH101497-01 NIH/NIMH
The project examined the impact of selective serotonin reuptake inhibitors and cognitive behavioral therapy on negative valence systems (NVS) constructs, particularly the Fronto-Limbic Affect Regulation and Emotional Salience brain circuit, and to elucidate whether NVS constructs at pre-treatment predicts
treatment response across internalizing psychopathologies.
K23 MH093679-01A2 NIH/NIMH
In the context of Cognitive Behavioral Therapy, the project proposes to perform pre- and post-treatment functional MRI of limbic-prefrontal circuitry in patients with social anxiety disorder to examine brain markers of response to therapy and treatment-related brain changes.
Brain & Behavior Research Foundation (formerly NARSAD)
The objective of this study is to broaden the clinical impact of an existing NIMH-funded K23 Career
Development Award project by including individuals with major depressive disorder. The project involves longitudinal fMRI and EEG measures of socio-emotional processing and emotion regulation before and after CBT.
Campus Research Board Pilot Grant OVCR Research Development Services, University of Illinois Chicago, Chicago, IL
This study integrates actigraphy, an objective measure of sleep and activity-rest cycles, into several ongoing studies at the University of Illinois, which examine anxiety and mood disorders across the lifespan in order to test the feasibility of actigraphy.
UL1RR024986 NIH funded CTSA institutional training program, University of Michigan, Ann Arbor, MI
This study uses fMRI to examine the neural correlates of attentional control over threat-relevant stimuli in individuals with social anxiety disorder.
Other Role: Postdoctoral Fellow Scholar